Product
HRS9432
1 clinical trial
1 indication
Indication
Candidemia and Invasive CandidiasisClinical trial
A Multi-centre, Randomized, Double-blind, Active Controlled, Parallel Groups, Phase II Study to Evaluate the Efficacy and Safety of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive CandidiasisStatus: Not yet recruiting, Estimated PCD: 2026-06-01